AbCellera Biologics Total Current Liabilities

AbCellera Biologics (ABCL) currently reports a total current liabilities of $53M as of June 2026. That compares with $67M in the prior-year period — down 20.6% year over year. Use the charts on this page to explore AbCellera Biologics's total current liabilities history and peer comparisons.

AbCellera Biologics's total current liabilities decreased from $67M to $53M — a 20.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AbCellera Biologics reported $53M in total current liabilities as of June 2026. That compares with $67M in the prior-year period — down 20.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $53M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AbCellera Biologics, and consider following ABCL for alerts when major investors trade the stock.